The UK needs to be prepared for a steep rise in the number of young adults affected by a severe form of lung disease due to their regular cannabis and tobacco use - lung specialists will tell the British Thoracic Society ...
Dec 11, 2014
0
0
Scientists at the Helmholtz Zentrum München (HMGU) working in cooperation with the Ludwig-Maximilians-Universität Hospital (KUM) and the Technischen Universität München (TUM) tested for the first time X-ray dark-field ...
May 27, 2014
0
0
Coinciding with the launch of a dedicated Lung Health Research Centre, researchers at the University of Melbourne have discovered a new insight into the unexplained link between lung infections, emphysema and lung cancer.
Apr 11, 2014
0
0
Seven years ago, Keith Brown decided to skip the elevator and take the stairs to the ninth floor of the Chicago parking garage where he worked.
Nov 19, 2013
0
0
Drug ads often warn of serious side effects, from nausea and bleeding to blindness, even death. New research suggests that, rather than scaring consumers away, these warnings can improve consumers' opinions and increase product ...
Sep 24, 2013
0
0
Scientists at the National Institute of Standards and Technology (NIST) have developed a new standard reference material (SRM), the first such measurement tool to enable hospitals to link important tissue density measurements ...
Jul 24, 2013
0
0
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
May 21, 2013
0
1
A small, easily implantable device called the Lung Volume Reduction Coil (LVRC) may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial ...
May 20, 2013
0
1
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.
May 10, 2013
0
0
A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.
Apr 17, 2013
0
0
